Annual report pursuant to Section 13 and 15(d)

Schedule of Deferred Tax Assets (Details)

v3.24.1
Schedule of Deferred Tax Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards – Federal and state $ 17,943 $ 14,614
Net operating loss carryforwards – Israel 18,740 18,813
Share-based compensation 975 1,735
Capitalized research and development 2,184 1,698
Accrued liabilities and reserves 409 681
Total deferred tax assets 40,251 37,541
Right of use asset (52) (109)
Other (39) (34)
Total deferred tax liabilities (91) (143)
Net deferred tax assets before valuation allowance 40,160 37,398
Valuation allowance (40,160) (37,398)
Net deferred tax assets after valuation allowance